These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9416280)

  • 1. Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage.
    Mima T; Mostafa MG; Mori K
    Acta Neurochir Suppl; 1997; 70():65-7. PubMed ID: 9416280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cerebral vasospasm by actinomycin D.
    Shigeno T; Mima T; Yanagisawa M; Saito A; Goto K; Yamashita K; Takenouchi T; Matsuura N; Yamasaki Y; Yamada K
    J Neurosurg; 1991 Jun; 74(6):940-3. PubMed ID: 2033454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid.
    Matsumura Y; Ikegawa R; Suzuki Y; Takaoka M; Uchida T; Kido H; Shinyama H; Hayashi K; Watanabe M; Morimoto S
    Life Sci; 1991; 49(11):841-8. PubMed ID: 1875792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.
    Kwan AL; Bavbek M; Jeng AY; Maniara W; Toyoda T; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1997 Aug; 87(2):281-6. PubMed ID: 9254094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
    Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
    Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Yanamoto H; Kikuchi H; Okamoto S
    Surg Neurol; 1994 Nov; 42(5):382-7. PubMed ID: 7974141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
    Zimmermann M; Seifert V
    Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.
    Clozel M; Watanabe H
    Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage.
    Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS
    Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11 -yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on cerebral vasospasm and impairment of cerebral circulation in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Aug; 46(8):746-50. PubMed ID: 9125271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model.
    Yamaguchi-Okada M; Nishizawa S; Mizutani A; Namba H
    Cerebrovasc Dis; 2009; 28(2):135-42. PubMed ID: 19506373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.